HIGHLIGHTS
- who: Paolo Monardo and Antonio Lacquaniti from the Papardo Hospital have published the paper: Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies, in the Journal: (JOURNAL) of 13/07/2022
- future: In the near future these tools will support nephrologist decision-making with a high potential for improving CV outcomes.
SUMMARY
In HD patients, the accumulation of uremic toxins, molecules exerting adverse biological activity at high concentrations, affects the patients` survival rate and quality of life. Up to date, personalization represents a better option for dialysis recommendation, according . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.